about
Lipoprotein(a) promotes smooth muscle cell proliferation and dedifferentiation in atherosclerotic lesions of human apo(a) transgenic rabbitsRelationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjectsLipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biologyPlasminogen on the surfaces of fibrin clots prevents adhesion of leukocytes and platelets.Lp(a) is not associated with diabetes but affects fibrinolysis and clot structure ex vivo.Features of two proteins of Leptospira interrogans with potential role in host-pathogen interactionsIdentification of fibrin clot-bound plasma proteins.Increased stroke risk and lipoprotein(a) in a multiethnic community: the Northern Manhattan Stroke Study.A Phase II Multicenter Trial With Rivaroxaban in the Treatment of Livedoid Vasculopathy Assessing Pain on a Visual Analog Scale.A comparative study on serum lipoprotein (a) and lipid profile between rheumatoid arthritis patients and normal subjects.The novel leptospiral surface adhesin Lsa20 binds laminin and human plasminogen and is probably expressed during infection.Association of Apo(a)isoform size with dyslipoproteinemia in male venous thrombosis patients.Identification of quantitative trait loci for fibrin clot phenotypes: the EuroCLOT studyLipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?Effect of Two Lipoprotein (a)-Associated Genetic Variants on Plasminogen Levels and Fibrinolysis.Inhibition of plasminogen activation by apo(a): role of carboxyl-terminal lysines and identification of inhibitory domains in apo(a).Fibrin Formation, Structure and Properties.Lipoprotein(a) in patients with aortic stenosis: Insights from cardiovascular magnetic resonance.Fibrinogen, Lp(a), Microalbuminuria and Left Ventricular Mass Index: Cardiovascular Disease Risk factors in Diabetes
P2860
Q24669902-671862E1-6936-427E-ADAB-876C101A7B8EQ24792333-62310944-43A9-42F3-853E-A6453C6200A8Q30242031-40CF831F-0EF8-44D4-BA1C-5A32B209ACC1Q30660580-31CD7482-3813-4E11-9E09-486DC7211F61Q33766882-60939981-F306-44F0-B09D-05651509FB3BQ34214710-439C95C6-67CA-4994-A2E4-FFC930CAFE90Q34369173-DB7268C0-A879-4248-AEC9-EE5F5923CB60Q34724879-F89D5724-C7A4-461D-AF52-286DFD658FA3Q34766309-160E9BB9-EEEC-4DA0-A801-80F803D6F260Q35631101-1419D586-8A65-447B-99CB-DDA8C45792E3Q35671562-392426DF-BB2C-4D3F-8CBF-1D3223A0F0D8Q36189302-6E867F1A-DECE-4277-B36A-F5488187BE38Q36429404-E9510119-9B80-4FD0-B348-1B7D55BC7C9EQ36843336-CEFDB7E1-D798-4473-B56E-8DEF731A1CECQ37401506-84382D58-07DD-427F-9B6D-64D4EB9CD8FBQ38528622-7297ECE0-C780-40BF-A64F-CCC44DF05E97Q39013217-327EE983-4EDA-4B72-AB2C-59E3523A9A03Q39555199-A5C2B101-9FFC-4523-916C-0FC896336E67Q41544636-60C4801A-7F4B-4AED-BC62-160463F965D0
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Inhibition of fibrinolysis by lipoprotein
@nl
Inhibition of fibrinolysis by lipoprotein(a).
@ast
Inhibition of fibrinolysis by lipoprotein(a).
@en
type
label
Inhibition of fibrinolysis by lipoprotein
@nl
Inhibition of fibrinolysis by lipoprotein(a).
@ast
Inhibition of fibrinolysis by lipoprotein(a).
@en
prefLabel
Inhibition of fibrinolysis by lipoprotein
@nl
Inhibition of fibrinolysis by lipoprotein(a).
@ast
Inhibition of fibrinolysis by lipoprotein(a).
@en
P1476
Inhibition of fibrinolysis by lipoprotein(a)
@en
P2093
A de la Peña Díaz
E Anglés-Cano
P304
P356
10.1111/J.1749-6632.2001.TB03514.X
P407
P577
2001-01-01T00:00:00Z